Jiangsu Provincial Center for Disease Control and Prevention Hospital
Recent work: A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector)
Technology:
COVID Labs/Universities
Industry:
COVID R&D
Headquarters:
China
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership